The Patent Finder

Elanco US Inc.

75 patents currently held · Updated Nov 21, 2026
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Novartis Animal Health US, Inc. (to 2015)

12
Ending by 2030
Mar 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 11, 2027
    The maintenance fee for Anti-IL31 Antibodies for Veterinary Use (US 11,697,683) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Feb 28, 2027
    The maintenance fee for Therapeutic Clay Compositions and Methods of Using (US 11,738,045) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
  • 2 fees due Jun 8 to 30, 2027 · next Jun 8
  • 1 fee due Jul 9, 2027
    The maintenance fee for Methods and Formulations for Reducing Bovine Emissions (US 11,864,567) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Aug 9, 2027
    The maintenance fee for Parasiticidal Dihydroisoxazole Compounds (US 9,255,111) comes due Aug 9, 2027. Unpaid by Feb 9, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for IL4/IL13 receptor molecule for veterinary use (US 11,970,526) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,943,670Liquid Formulations of Ractopamine
In force
 · High confidence
In forceHigh confidence
US 7,846,960FXR Agonists
In force
 · High confidence
In forceHigh confidence
US 7,863,302Compounds and Methods for Modulating Fx-Receptors
In force
 · High confidence
In forceHigh confidence
US 8,778,648Enzymes for Reduced Immunological Stress
In force
 · Medium confidence
In forceMedium confidence
US 8,862,481Method And System For Collecting, Managing and Reporting Feedlot Data And Feed Additive Consumption Data
In force
 · Medium confidence
In forceMedium confidence
US 8,106,077Compounds and Methods for Modulating FXR
In force
 · High confidence
In forceHigh confidence
US 9,820,977Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
In force
 · USPTO record
In forceUSPTO record
US 7,914,782Enzymes for Reduced Immunological Stress
In force
 · High confidence
In forceHigh confidence
US 11,542,310Modified Bovine G-CSF Polypeptides And Their Uses
In force
 · High confidence
In forceHigh confidence
US 12,612,440Modified Bovine G-Csf Polypeptides and Their Uses
In force
 · Medium confidence
In forceMedium confidence
10 of 75 patents shown.
Pro members see all 75.
Pro members: see all 75 patents
Also on record, not counted in the 75: 12 patents in force now held by others · 13 lapsed for an unpaid fee · 53 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

19 pending · 4 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited